CurrentCardio coverage · page 2 of 4

American Heart Journal

Briefs 41–80 of 150 CurrentCardio has covered from this journal, newest publication first

Latest from American Heart Journal

All coverage, newest first

Am Heart J31 Jul 2026
Reconsidering fibrinolysis in selected patients with non–ST-elevation acute coronary syndrome: A hypothesis-generating, research-based framework
Research articleCoronary & ACS
Am Heart J25 Jul 2026
Rationale, design, and experiences from the vanguard phase of the bariatric surgery for the reduction of cardiovascular events (BRAVE) trial
Trial designCardiometabolic & kidney
Am Heart J24 Jul 2026
Intensive blood-pressure control for the prevention of major cardiovascular events in patients with type 2 diabetes: Rationale, design and baseline characteristics of the OPTIMAL-DIABETES randomized trial
Trial designHypertension
Am Heart J22 Jul 2026
Rationale and design of the TAILOR-HCM multicenter randomized controlled trial: Transapical beating-heart septal myectomy for obstructive hypertrophic cardiomyopathy
Trial designHeart failure
Am Heart J15 Jul 2026
Design, rationale, and baseline patient characteristics for the Sickle Cell Disease and CardiovAscular Risk-Red cell Exchange (SCD-CARRE) trial
Trial designCardio-oncology & other
Am Heart J11 Jul 2026
Interpreting apparent differences among the major colchicine trials for cardiovascular prevention: A descriptive compatibility analysis
Research articlePrevention & lipids
Am Heart J11 Jul 2026
Antegrade dissection and re-entry vs retrograde strategy in chronic total occlusion percutaneous coronary intervention: Rationale and design of the ADRENALINE randomized study
Trial designCoronary & ACS
Am Heart J11 Jul 2026
Integrative assessment of high-sensitivity C-reactive protein and lipid levels in predicting 20-year atherosclerotic cardiovascular disease risk, in a Mediterranean population: The ATTICA study (2002-2022)
Cohort studyPrevention & lipids
Am Heart J8 Jul 2026
Comparative effectiveness of torsemide vs furosemide in the management of heart failure patients: Win-ratio reanalysis of the TRANSFORM-HF trial
Secondary analysisHeart failure
Am Heart J6 Jul 2026
International study of coronary microvascular angina (iCorMicA): A registry-based diagnostic study and nested randomized trial
Trial designCoronary & ACS
Am Heart J2 Jul 2026
Revised lipid-lowering therapy guidelines in a nationally representative sample
Cross-sectional studyPrevention & lipids
Am Heart J2 Jul 2026
Stratified medicine with eplerenone for myocardial infarction or injury and no obstructive coronary arteries: A registry-based basket trial
Trial designCoronary & ACS
Am Heart J1 Jul 2026
Cardiometabolic health of low- and higher-income adults in the United States, 2009-2023
Cross-sectional studyCardiometabolic & kidney
Am Heart J23 Jun 2026
DOAC score among patients receiving Vitamin K antagonists
Diagnostic or prognostic studyArrhythmias & EP
Am Heart J22 Jun 2026
Considerations for using atrial fibrillation burden as a surrogate endpoint: A report from the Cardiovascular Sciences Research Consortium
Guideline or statementArrhythmias & EP
Am Heart J21 Jun 2026
Prognostic impact of combined inflammatory markers in patients undergoing percutaneous coronary intervention
Research articleCoronary & ACS
Am Heart J20 Jun 2026
Lessons learned from the feasibility phase of the REvascularization CHoices Among Under-Represented Groups Evaluation (RECHARGE) trial program
Randomised controlled trialCoronary & ACS
Am Heart J20 Jun 2026
The association of single ventricle morphology with long term quality of life among survivors: A report from congenital heart disease project to understand lifelong survivor experience (CHD PULSE)
Cross-sectional studyCongenital
Am Heart J19 Jun 2026
Registry of atrial fibrillation in Latin America: Primary results of the LACROSS study
Cohort studyArrhythmias & EP
Am Heart J17 Jun 2026
Prognostic value of left ventricular contractility index in patients with coarctation of aorta and preserved ejection fraction
Cohort study
Am Heart J16 Jun 2026
The effect of zalunfiban on high sensitivity cardiac troponin and the association with clinical outcomes in patients with STEMI
Secondary analysisCoronary & ACS
Am Heart J9 Jun 2026
Clinical profiles to guide decongestion in acute heart failure
Meta-analysisHeart failure
Am Heart J6 Jun 2026
Clinical outcomes and impact of aortic valve replacement in concordant vs discordant high-gradient aortic stenosis
Research articleValvular & structural
Am Heart J3 Jun 2026
Toward developing a patient reported outcomes measure for children with heart failure: A qualitative study design
Research articleHeart failure
Am Heart J3 Jun 2026
Cardio-kidney-metabolic overlap in patients with severe heart failure: Data from the HELP-HF registry
Cohort studyHeart failure
Am Heart J1 Jun 2026
A pragmatic randomized trial to evaluate the vaccine effectiveness of bivalent RSV prefusion F vaccine for preventing RSV hospitalizations in adults (DAN-RSV): Trial design update
Trial designCardio-oncology & other
Am Heart J30 May 2026
Evaluation, treatment, and outcomes in patients with possible severe aortic stenosis
Cohort studyValvular & structural
Am Heart J27 May 2026
Potentially futile outcome after uncomplicated TAVI: Insights from the TRITAVI registry
Cohort studyValvular & structural
Am Heart J27 May 2026
Progression of bicuspid-related aortopathy in patients undergoing transcatheter aortic valve implantation: Rationale and design of the international, multicenter PROSPERO-TAVI registry
Trial designValvular & structural
Am Heart J26 May 2026
Relationship between baseline patient-reported health status and patient-centered outcomes after transcatheter aortic valve replacement
Secondary analysisValvular & structural
Am Heart J26 May 2026
Design of VICTORION-2 Prevent: A randomized double-blind, placebo-controlled trial, assessing the impact of inclisiran on major adverse cardiovascular events in patients with established cardiovascular disease
Trial designPrevention & lipids
Am Heart J21 May 2026
Evaluation of high intensity interval training in patients with a right ventricle to pulmonary artery conduit in a randomized controlled trial: Rationale and design of the "Right HIIT" study
Trial designCongenital
Am Heart J20 May 2026
Direct His/LBB pacing as an alternative to biventricular pacing in patients with HFrEF and a typical LBBB: Design and rationale for the His-Alternative II trial
Trial designHeart failure
Am Heart J19 May 2026
Predictors of ischemic stroke and major bleeding among patients with atrial fibrillation in clinical practice
Diagnostic or prognostic studyArrhythmias & EP
Am Heart J17 May 2026
Direct oral anticoagulant monotherapy vs combination therapy with antiplatelets in chronic coronary syndrome patients with prior percutaneous coronary intervention requiring anticoagulation: A meta-analysis
Meta-analysisCoronary & ACS
Am Heart J15 May 2026
Impact of malnutrition on outcomes among elderly ST-Elevation myocardial infarction patients receiving primary percutaneous coronary intervention
Cohort studyCoronary & ACS
Am Heart J8 May 2026
High-intensity interval training combined with moderate-intensity continuous training in post-PCI acute myocardial infarction patients: A randomized controlled trial
Randomised controlled trialCoronary & ACS
Am Heart J8 May 2026
Left atrial appendage closure in patients with non-valvular atrial fibrillation and end stage chronic KIDNEY disease: Rationale and design of the prospective randomized LAA-KIDNEY trial
Trial designArrhythmias & EP
Am Heart J8 May 2026
Women’s health initiative strong and healthy silent atrial fibrillation recording study: Rationale, study design, and baseline data
Trial designArrhythmias & EP
Am Heart J7 May 2026
Design and rationale of the Radial Access Insertion Sheath Evaluation via the electronic medical record (RAISE-EMR) study
Trial designCoronary & ACS

All 150 Briefs in ExploreShowing Briefs 41–80 of 150, newest first